Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for HIV-1 drug resistance.

G J Hanna1, A M Caliendo

  • 1Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. hannag@msx.dept-med.pitt.edu

Molecular Diagnosis : a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology
|January 5, 2002
PubMed
Summary

Understanding HIV-1 drug resistance is crucial for effective treatment. Resistance testing, using genotypic or phenotypic assays, aids in managing treatment failure and guiding therapy in specific patient groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progression patterns and clinical outcomes in patients with cutaneous squamous-cell carcinoma following anti-PD-1 therapy failure.

ESMO open·2026
Same author

First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.

ESMO open·2024
Same author

Accuracy of quantitative viral secondary standards: a re-examination.

Journal of clinical microbiology·2024
Same author

Matrix Matters: Assessment of Commutability among BK Virus Assays and Standards.

Journal of clinical microbiology·2022
Same author

Persistent Challenges of Interassay Variability in Transplant Viral Load Testing.

Journal of clinical microbiology·2020
Same author

Impact of Fragmentation on Commutability of Epstein-Barr Virus and Cytomegalovirus Quantitative Standards.

Journal of clinical microbiology·2019

Area of Science:

  • Virology
  • Infectious Diseases
  • Pharmacogenomics

Background:

  • Viral resistance to antiretroviral therapy (ART) poses a significant challenge to managing Human Immunodeficiency Virus type 1 (HIV-1) infection.
  • Diverse mutational patterns and complex cross-resistance within antiretroviral drug classes complicate treatment strategies.
  • Current diagnostic methods for HIV-1 drug resistance include genotypic and phenotypic assays, each with distinct advantages and limitations.

Purpose of the Study:

  • To review the landscape of HIV-1 drug resistance, including underlying mechanisms and testing methodologies.
  • To evaluate the clinical utility and impact of HIV-1 drug resistance testing on virologic outcomes.
  • To provide recommendations for the appropriate use of resistance testing in clinical practice.

Main Methods:

Related Experiment Videos

  • Review of prospective clinical trials evaluating genotypic and phenotypic HIV-1 drug resistance testing.
  • Analysis of data on the efficacy and limitations of different resistance assay types.
  • Synthesis of current clinical recommendations for HIV-1 drug resistance testing.

Main Results:

  • Genotypic assays have demonstrated significant but modest improvements in virologic outcomes in clinical trials.
  • Phenotypic resistance testing has shown variable success in improving virologic outcomes across different studies.
  • Resistance testing is recommended for patients experiencing virologic failure, poor response to ART, and for pregnant women.

Conclusions:

  • HIV-1 drug resistance testing is a valuable tool for optimizing antiretroviral therapy, particularly in cases of treatment failure.
  • Consideration of resistance testing in treatment-naive patients is warranted in regions with high prevalence of transmitted drug-resistant HIV-1.
  • Further research may clarify the optimal role and interpretation of resistance testing in various clinical scenarios.